NSC |
Compound |
Enrichment |
Correlation |
NSC 663286 |
7-Chloro-6-N-(2-fluoroethylamino)-5,8-quinolinedione |
0.0312262198176281 |
0.19523661 |
NSC 666113 |
Null |
0.0312262198176281 |
0.4971992 |
NSC 678144 |
4H-1,3,6,2-Dioxazaphosphocinium, 4-hexadecyltetrahydro- 2,6,6-trimethyl-, bromide, 2-oxide |
0.0312262198176281 |
0.12166494 |
NSC 717838 |
Null |
0.0312262198176281 |
-0.22850043 |
NSC 743244 |
Null |
0.0312262198176281 |
0.48527951 |
NSC 744020 |
methyl 1-(4-[(11aR)-7-methoxy-5-oxo-2,3,5,11a-tetrahydro-1H-benzo[e]pyrrolo[1,2-a][1,4]diazepin-8-yl]oxybutyl)-2-(1-methyl-1H-3-indolyl)-1H-benzo[d]imidazole-6-carboxylate |
0.0312262198176283 |
0.41478895 |
NSC 79304 |
Null |
0.0312262198176283 |
0.6940808 |
NSC 745321 |
Null |
0.0314734733353265 |
0.34094392 |
NSC 750685 |
Null |
0.0314734733353265 |
0.46880126 |
NSC 132791 |
Butyric acid, 2-hydroxy-2-methyl-, 4-ester with 1,3a.beta.,4,7,7a.alpha.,11,11a,11b.alpha.-octahydro-1.alpha.,2.alpha.,4.beta.,11.beta.-tetrahydroxy-3.alpha.,8,11a.beta.-trimethyl-2H-1,11c.beta.-(epo |
0.0314734733353267 |
0.37909559 |